Belpointe Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-660
Closed -$23.5K 3651
2023
Q1
$23.5K Buy
660
+234
+55% +$8.49K ﹤0.01% 2217
2022
Q4
$15.6K Buy
+426
New +$16.8K ﹤0.01% 2358

Other funds holding SYNH

Belpointe Asset Management's SYNH Position: Q2 2023 in Review

Belpointe Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 660 shares — an estimated $23.5K sold.

Belpointe Asset Management first reported a position in SYNH in Q4 2022 and held it in 2 quarters. The position peaked at $23.5K in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Belpointe Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 660 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $23.5K.
  • Belpointe Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $23.5K in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.